Company overview
Basic information
Company name
Šiltas medis, UAB
Company code
303832877
VAT code
LT100009317319
Registered address
Kauno r. sav., Zapyškio sen., Jadagonių k., Žibučių g. 7, LT-53403
Registration date
2015-03-04
Company age: 11 y. 7 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Website
https://www.kingsauna.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
New construction
Ownership form
Private without foreign capital
UAB "Šiltas medis"
Company code: 303832877
Address: Kauno r. sav., Zapyškio sen., Jadagonių k., Žibučių g. 7, LT-53403
VAT code: LT100009317319
Description
This description was generated by artificial intelligence.
Šiltas medis, UAB (company code 303832877) is an operational private limited liability company registered in 2015. It is a private enterprise in the national private non-financial companies sector, under private ownership, with governance described as CEO only. The company’s main activity is EVRK code F.41.00.10, New construction. It is located in Jadagoniu k., Zapyškio sen., Kauno r. sav., Kauno apskr.
The company remains small in scale and is classified as micro, with average employment at 1 in 2024 and 2025, and 1 so far in 2026. No wage information is provided. Financially, Šiltas medis, UAB generated revenue of EUR 40.3K in 2025, up 174.3% year on year and 35.1% over two years. Despite the stronger turnover, the company continued to post a loss: net profit was EUR -10.9K in 2025, with a profit margin of -27.0%. This followed revenue of EUR 14.7K and a net loss of EUR -25.7K in 2024, compared with EUR 29.8K revenue and a net loss of EUR -12.2K in 2023. Share capital is EUR 2.5K.
The company remains small in scale and is classified as micro, with average employment at 1 in 2024 and 2025, and 1 so far in 2026. No wage information is provided. Financially, Šiltas medis, UAB generated revenue of EUR 40.3K in 2025, up 174.3% year on year and 35.1% over two years. Despite the stronger turnover, the company continued to post a loss: net profit was EUR -10.9K in 2025, with a profit margin of -27.0%. This followed revenue of EUR 14.7K and a net loss of EUR -25.7K in 2024, compared with EUR 29.8K revenue and a net loss of EUR -12.2K in 2023. Share capital is EUR 2.5K.
Download a detailed company report
Make confident decisions with all the information about Šiltas medis, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.